Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker, H. Glantz, E. Thunström, A. Kallryd, J. Ejdebäck, J. Herlitz (Skövde and Lidköping, Gothenburg, Sweden). High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial. Eur Respir J 2008; 32: Suppl. 52, 830

Member's Comments

No comment yet.

Related content which might interest you: Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up Source: Eur Respir J 2006; 28: 596-602 Year: 2006 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Late Breaking Abstract: Baseline characteristics of the revascularized patients with coronary artery disease and obstructive sleep apnoea in the RICCADSA trial Source: Annual Congress 2010 - Sleep apnoea: insights from basic and clinical research Year: 2010 Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults Year: 2011 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease Source: International Congress 2017 – CPAP therapy Year: 2017 Obstructive sleep apnoea and coronary artery disease Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities Year: 2016 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Depression and response to CPAP treatment in coronary artery disease patients with sleepy vs nonsleepy obstructive slee apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Changes in extracranial arteries in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 69-74 Year: 2005